Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) EPS (diluted)

Alert me on EPS (diluted)

Revvity Inc.'s EPS (diluted) for fiscal 2025 was $2.07, down 5.91% from $2.20 in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.10. Over the past ten years it has ranged from $1.87 (fiscal 2015) to $7.99 (fiscal 2021); the current reading is higher than 27% of that period. Revvity Inc. ranks 14th of 52 Diagnostics & Research companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $2.07 (5.91%)
FY2024 $2.20 (60.36%)
FY2023 $5.55 21.18%
FY2022 $4.58 (42.68%)
FY2021 $7.99 23.11%
FY2020 $6.49 218.14%
FY2019 $2.04 (4.23%)
FY2018 $2.13 (19.32%)
FY2017 $2.64 24.53%
FY2016 $2.12 13.37%

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $0.47 30.56%
Mar 2026 $0.36 (58.62%)
Dec 2025 $0.87 117.50%
Sep 2025 $0.40 (13.04%)
42 more quarters

Against its own ten years

Low $1.87 High $7.99
Ten-year median $2.20
Current reading's percentile 27

EPS (diluted) against peers

Company EPS (diluted)
MEDP Medpace Holdings, Inc. compare $17.06
LH Labcorp Holdings Inc. compare $12.09
DGX Quest Diagnostics Incorporated compare $9.42
RVTY Revvity Inc. $2.10
QGEN QIAGEN N.V. compare $1.95
ICLR ICON PLC compare $0.66
TWST Twist Bioscience Corporation compare −$2.22
GH Guardant Health, Inc. compare −$3.49
CRL Charles River Laboratories International, Inc. compare −$4.85

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on RVTY